aurelie bedel

Has grant

MCU-PH, Associate professor and clinician

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

CRISPR-Genotox

Open Date:

Close Date:

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (9)

Mari DeMarco

Clinical Professor

The University of British Columbia

CANADA

View details

Béatrice Turcq

CNRS Délégation Aquitaine-Limousin

FRANCE

View details

Thomas Daubon

University of Bordeaux

FRANCE

View details

Julian Boutin

Associate Professor

FRANCE

View details

Joris Guyon

Associate Professor

Centre Hospitalier Universitaire Vaudois

FRANCE

View details

Samuel Amintas

FRANCE

View details

Anne FOGLI

Université Clermont Auvergne

FRANCE

View details

Jean-Paul Concordet

INSERM

FRANCE

View details

Olivier BOUSIGES

Associate professor

University of Strasbourg

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

aurelie bedel

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9.

Specific High-Sensitivity Enzymatic Reporter UnLOCKing-Mediated Detection of Oncogenic <i>BCR::ABL1</i> and <i>EGFR</i> Rearrangements.

An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid

Neurofilaments contribution in clinic: state of the art.

Neurofilaments: a key new biomarker for clinicians. Part 1: Importance of neurofilaments in the management of neurodegenerative diseases

Neurofilaments: a key new biomarker for clinicians. Part 2: Neurofilaments, an asset beyond neurodegenerative diseases

Bioactive food components for colorectal cancer prevention and treatment: A good match.

ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected.

Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview

Recent Progress in Genome Editing for Gene Therapy Applications: The French Perspective.

Collaborators (9)

Mari DeMarco

Béatrice Turcq

Thomas Daubon

Julian Boutin

Joris Guyon

Samuel Amintas

Anne FOGLI

Jean-Paul Concordet

Olivier BOUSIGES

Make your next move.